Tuberculosis and Respiratory Diseases

  • 제85권2호
  • /
  • Pages.101-110
  • /
  • 2022
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Status of Studies Investigating Asthma-Chronic Obstructive Pulmonary Disease Overlap in Korea: A Review

  • Jo, Yong Suk (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • 투고 : 2021.09.13
  • 심사 : 2021.12.02
  • 발행 : 2022.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

There is a considerable number of individuals who exhibit features of both asthma and chronic obstructive pulmonary disease (COPD), defined as asthma-COPD overlap (ACO). Many studies have reported that these patients have a greater burden of symptoms, including cough and dyspnea, and experience more exacerbations and hospitalizations than those with non-ACO COPD or asthma. Although diagnostic criteria for ACO have not yet been clearly established, their clinical significance remains to be determined. As interest in ACO grows, related studies have been conducted in South Korea as well. The present review summarizes ACO-related studies in South Korea to better understand Korean ACO patients and guide further research. Several cohort studies of asthma and COPD and population-based studies for ACO were reviewed and the key results from demographics, clinical features, lung function, biomarkers, treatment, and prognosis were summarized.

키워드

참고문헌

  1. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35. https://doi.org/10.1136/thx.2008.108027
  2. Global Initiative for Asthma. Global strategy for asthma management and prevention: 2021 upeate [Internet]. Fontana: Global Initiative for Asthma; 2021 [cited 2021 Mar 15]. Available from: http://www.ginasthma.org.
  3. Lee HY, Kang JY, Yoon HK, Lee SY, Kwon SS, Kim YK, et al. Clinical characteristics of asthma combined with COPD feature. Yonsei Med J 2014;55:980-6. https://doi.org/10.3349/ymj.2014.55.4.980
  4. Park SY, Jung H, Kim JH, Seo B, Kwon OY, Choi S, et al. Longitudinal analysis to better characterize Asthma-COPD overlap syndrome: findings from an adult asthma cohort in Korea (COREA). Clin Exp Allergy 2019;49:603-14. https://doi.org/10.1111/cea.13339
  5. Lee H, Kim SH, Kim BK, Lee Y, Lee HY, Ban GY, et al. Characteristics of specialist-diagnosed asthma-COPD overlap in severe asthma: observations from the Korean Severe Asthma Registry (KoSAR). Allergy 2021;76:223-32. https://doi.org/10.1111/all.14483
  6. Kim MA, Noh CS, Chang YJ, Hong YK, Lee JS, Lee SW, et al. Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation. Int J Tuberc Lung Dis 2015;19:864-9. https://doi.org/10.5588/ijtld.14.0327
  7. Cosio BG, Soriano JB, Lopez-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest 2016;149:45-52. https://doi.org/10.1378/chest.15-1055
  8. Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 2016;48:664-73. https://doi.org/10.1183/13993003.00436-2016
  9. Menezes AM, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297-304. https://doi.org/10.1378/chest.13-0622
  10. Jo YS, Lee J, Yoon HI, Kim DK, Yoo CG, Lee CH. Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria. Ann Allergy Asthma Immunol 2017;118:696-703. https://doi.org/10.1016/j.anai.2017.04.010
  11. Lee JH, Rhee CK, Kim K, Kim JA, Kim SH, Yoo KH, et al. Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications. Int J Chron Obstruct Pulmon Dis 2017;12:1135-44. https://doi.org/10.2147/COPD.S130140
  12. Park HJ, Byun MK, Kim HJ, Ahn CM, Lee JH, Shin KC, et al. Asthma-COPD overlap shows favorable clinical outcomes compared to pure COPD in a Korean COPD cohort. Allergy Asthma Immunol Res 2017;9:431-7. https://doi.org/10.4168/aair.2017.9.5.431
  13. Jo YS, Hwang YI, Yoo KH, Kim TH, Lee MG, Lee SH, et al. Effect of inhaled corticosteroids on exacerbation of asthma-COPD overlap according to different diagnostic criteria. J Allergy Clin Immunol Pract 2020;8:1625-33. https://doi.org/10.1016/j.jaip.2020.01.004
  14. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29. https://doi.org/10.1164/ajrccm.161.1.ats11-99
  15. Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS, et al. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res 2009;10:4. https://doi.org/10.1186/1465-9921-10-4
  16. Plaza V, Alvarez F, Calle M, Casanova C, Cosio BG, Lopez-Vina A, et al. Consensus on the Asthma-COPD Overlap Syndrome (ACOS) between the Spanish COPD guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). Arch Bronconeumol 2017;53:443-9.
  17. Kim MH, Rhee CK, Kim K, Kim SH, Lee JY, Kim YH, et al. Heterogeneity of asthma and COPD overlap. Int J Chron Obstruct Pulmon Dis 2018;13:1251-60. https://doi.org/10.2147/COPD.S152916
  18. Jo YS, Hwang YI, Yoo KH, Kim TH, Lee MG, Lee SH, et al. Comparing the different diagnostic criteria of asthma-COPD overlap. Allergy 2019;74:186-9. https://doi.org/10.1111/all.13577
  19. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014;11:163-70. https://doi.org/10.3109/15412555.2013.831061
  20. Kang HR, Hong SH, Ha SY, Kim TB, Lee EK. Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea. Respir Res 2019;20:80. https://doi.org/10.1186/s12931-019-1039-5
  21. Song JH, Lee CH, Kim DK, Yoon H, Byun MK, Rhee CK, et al. Differences in prevalence of asthma-COPD overlap according to different criteria. Medicine (Baltimore) 2018;97:e12049. https://doi.org/10.1097/MD.0000000000012049
  22. Park HY, Lee SY, Kang D, Cho J, Lee H, Lim SY, et al. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort. Respir Res 2018;19:36. https://doi.org/10.1186/s12931-018-0737-8
  23. Lee DW, Choi EY. A comparative study of bone mineral density among patients with obstructive lung diseases in Korea. Int J Tuberc Lung Dis 2015;19:1246-51. https://doi.org/10.5588/ijtld.15.0100
  24. Lee DW, Jin HJ, Shin KC, Chung JH, Lee HW, Lee KH. Presence of sarcopenia in asthma-COPD overlap syndrome may be a risk factor for decreased bone-mineral density, unlike asthma: Korean National Health and Nutrition Examination Survey (KNHANES) IV and V (2008-2011). Int J Chron Obstruct Pulmon Dis 2017;12:2355-62. https://doi.org/10.2147/COPD.S138497
  25. Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, Lopez-Vina A, et al. Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines. Eur Respir J 2017;49:1700068. https://doi.org/10.1183/13993003.00068-2017
  26. Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, et al. Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study. Int J Chron Obstruct Pulmon Dis 2018;13:1809-18. https://doi.org/10.2147/COPD.S163189
  27. Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, et al. Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study. Int J Chron Obstruct Pulmon Dis 2018;13:3411-7. https://doi.org/10.2147/COPD.S174545
  28. Jo YS, Kwon SO, Kim J, Kim WJ. Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap. J Thorac Dis 2018;10:5047-56. https://doi.org/10.21037/jtd.2018.07.86
  29. Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186:157-65. https://doi.org/10.1007/s00408-008-9071-0
  30. Hwang HJ, Lee SM, Seo JB, Lee JS, Kim N, Lee SW, et al. Visual and quantitative assessments of regional xenon-ventilation using dual-energy CT in asthma-chronic obstructive pulmonary disease overlap syndrome: a comparison with chronic obstructive pulmonary disease. Korean J Radiol 2020;21:1104-13. https://doi.org/10.3348/kjr.2019.0936
  31. Barrecheguren M, Pinto L, Mostafavi-Pour-Manshadi SM, Tan WC, Li PZ, Aaron SD, et al. Identification and definition of asthma-COPD overlap: The CanCOLD study. Respirology 2020;25:836-49. https://doi.org/10.1111/resp.13780
  32. Lim JU, Kim DK, Lee MG, Hwang YI, Shin KC, In KH, et al. Clinical characteristics and changes of clinical features in patients with asthma-COPD overlap in Korea according to different diagnostic criteria. Tuberc Respir Dis (Seoul) 2020;83(Suppl 1):S34-S45. https://doi.org/10.4046/trd.2020.0031
  33. Lee H, Rhee CK, Lee BJ, Choi DC, Kim JA, Kim SH, et al. Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database. Int J Chron Obstruct Pulmon Dis 2016;11:775-83. https://doi.org/10.2147/COPD.S95954
  34. Kim Y, Kim YJ, Kang YM, Cho WK. Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean population: a nationwide cohort study. BMC Pulm Med 2021;21:151. https://doi.org/10.1186/s12890-021-01497-4
  35. Lange P, Colak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med 2016;4:454-62. https://doi.org/10.1016/S2213-2600(16)00098-9
  36. Kumbhare S, Strange C. Mortality in asthma-chronic obstructive pulmonary disease overlap in the United States. South Med J 2018;111:293-8. https://doi.org/10.14423/smj.0000000000000807
  37. Baarnes CB, Andersen ZJ, Tjonneland A, Ulrik CS. Incidence and long-term outcome of severe asthma-COPD overlap compared to asthma and COPD alone: a 35-year prospective study of 57,053 middle-aged adults. Int J Chron Obstruct Pulmon Dis 2017;12:571-9. https://doi.org/10.2147/COPD.S123167
  38. van Boven JF, Roman-Rodriguez M, Palmer JF, Toledo-Pons N, Cosio BG, Soriano JB. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. Chest 2016;149:1011-20. https://doi.org/10.1016/j.chest.2015.12.002
  39. Peltola L, Patsi H, Harju T. COPD comorbidities predict high mortality: asthma-COPD-overlap has better prognosis. COPD 2020;17:366-72. https://doi.org/10.1080/15412555.2020.1783647
  40. Suzuki M, Makita H, Konno S, Shimizu K, Kimura H, Kimura H, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease: an analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med 2016;194:1358-65. https://doi.org/10.1164/rccm.201602-0353OC
  41. Lee H, Ryu J, Chung SJ, Park DW, Sohn JW, Yoon HJ, et al. Coexisting COPD increases mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study. Allergy Asthma Immunol Res 2020;12:821-31. https://doi.org/10.4168/aair.2020.12.5.821
  42. Lee YM, Lee JH, Kim HC, Ha E. Effects of PM10 on mortality in pure COPD and asthma-COPD overlap: difference in exposure duration, gender, and smoking status. Sci Rep 2020;10:2402. https://doi.org/10.1038/s41598-020-59246-2
  43. Kim J, Kim YS, Kim K, Oh YM, Yoo KH, Rhee CK, et al. Socioeconomic impact of asthma, chronic obstructive pulmonary disease and asthma-COPD overlap syndrome. J Thorac Dis 2017;9:1547-56. https://doi.org/10.21037/jtd.2017.05.07
  44. Joo H, Han D, Lee JH, Rhee CK. Heterogeneity of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2017;12:697-703. https://doi.org/10.2147/COPD.S130943
  45. Lim HS, Choi SM, Lee J, Park YS, Lee SM, Yim JJ, et al. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Ann Allergy Asthma Immunol 2014;113:652-7. https://doi.org/10.1016/j.anai.2014.08.021
  46. Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, et al. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2016;11:2797-803. https://doi.org/10.2147/COPD.S114964
  47. Park SY, Kim S, Kim JH, Kim SH, Lee T, Yoon SY, et al. A randomized, noninferiority trial comparing ICS + LABA with ICS + LABA + LAMA in asthma-COPD overlap (ACO) treatment: the ACO Treatment with Optimal Medications (ATOMIC) study. J Allergy Clin Immunol Pract 2021;9:1304-11. https://doi.org/10.1016/j.jaip.2020.09.066